Pecan (Carya illinoinensis)

Carya illinoinensis
Evidence Level
Limited
8 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Pecans are the nuts of the pecan hickory tree (Carya illinoinensis), eaten raw, roasted, chopped or ground. Per 100 g, USDA lists 691 kcal, 72 g of fat (40.8 g monounsaturated), 9.2 g of protein, 9.6 g of fiber and 24.4 mg of gamma-tocopherol, so a 28 g handful supplies about 194 kcal. In small trials of 4 to 12 weeks, 57 to 68 g a day lowered total and LDL cholesterol more than control diets, and a pooled analysis agreed, but found no clear change in blood sugar, body weight or blood pressure. These are blood markers. FDA will consider enforcement discretion for a qualified heart claim that covers most nuts, including pecans. Most US pecan trials were funded by pecan grower or sheller groups. Pecans are a tree nut, one of the nine major US food allergens.

Studied Dose Whole pecans: 57 to 68 g a day (about 2 to 2.4 oz) for 4 to 12 weeks in most trials; 30 g a day in a 12-week trial; 13% or 20% of daily energy in other trials, with no lipid change at 6%. FDA's qualified nut claim names 1.5 ounces (about 42 g) a day.
Active Compound Whole pecan kernels (Carya illinoinensis). Per 100 g, USDA lists 72.0 g of fat (40.8 g monounsaturated, mostly oleic acid; 21.6 g polyunsaturated, mostly linoleic acid; 6.2 g saturated), 9.2 g of protein, 9.6 g of fiber, 24.4 mg of gamma-tocopherol against 1.4 mg of alpha-tocopherol, 117 mg of beta-sitosterol and 4.5 mg of manganese. Trial authors also describe flavan-3-ols such as catechins; the USDA entry gives no polyphenol values.

Benefits

Total and LDL cholesterol levels

A pooled analysis of 10 trial reports found pecans lowered total cholesterol by 8.5 mg/dL, LDL by 7.4 mg/dL and triglycerides by 14.1 mg/dL more than control diets, rating certainty as low. In a 12-week trial in 138 adults, 57 g a day in place of usual snacks lowered LDL by 7.2 mg/dL compared with usual diet. These are blood markers, and most controls were not calorie-matched.

Lipid changes at different daily amounts

In 102 adults with excess weight or high blood lipids, pecans supplying 13% or 20% of daily energy, swapped for foods of equal calories for 4 weeks, lowered total cholesterol, LDL and apoB compared with a nut-free control, while 6% of energy did not. Fasting triglycerides did not differ. A pecan promotion board funded the trial.

Fasting insulin and insulin resistance markers

In a 4-week crossover feeding trial in 26 adults with overweight or obesity, pecans at 15% of energy lowered fasting insulin and HOMA-IR more than a calorie-matched nut-free diet, while glucose did not differ. A pooled analysis found no clear effect on fasting glucose, insulin or HOMA-IR, and a 12-week trial in 204 coronary patients found no change in glucose markers.

Body weight when pecans are added to the diet

Pecans supply about 194 kcal per 28 g. Over 8 weeks, 68 g a day raised weight about 1 kg against 0.3 kg in nut-free controls (a trend, P = 0.09), far below the 3.2 to 3.3 kg predicted from the added calories. In a 12-week trial, weight tended to rise 0.7 kg versus usual diet. Pooled trials found no change in weight.

Blood vessel function and blood pressure

In a 12-week trial in 138 adults, pecans did not change flow-mediated dilation, the primary outcome, arterial stiffness or blood pressure compared with usual diet. A 4-week trial in 44 older adults found no change in fasting vessel function, though two after-meal small-vessel measures differed. Pooled blood pressure results showed no clear effect, with high heterogeneity.

Gamma-tocopherol intake and diet quality

Per 100 g, pecans supply 24.4 mg of gamma-tocopherol and 1.4 mg of alpha-tocopherol. After a pecan test meal, plasma gamma-tocopherol doubled at 8 hours in 16 adults. In a 12-week trial, swapping usual snacks for 57 g of pecans a day raised the Healthy Eating Index by 9.4 points compared with usual diet. Health effects of these compounds are not established.

Mechanism of action

1

Monounsaturated fat in place of other foods

Pecan fat is mostly monounsaturated oleic acid. In a feeding trial, red blood cell oleic acid and total monounsaturated fat rose and palmitic acid fell with pecans compared with a matched control diet, and replacing a fifth of a Step I diet with pecans lowered LDL more than the Step I diet alone. Which pecan component drives the lipid change was not isolated.

2

ApoB and LDL particle number

In a 4-week trial in older adults, LDL particle number fell 126 nmol/L with pecans and rose 43 nmol/L in nut-free controls, and in a dose trial apoB fell at 13% and 20% of energy. ApoB and particle counts reflect how many cholesterol-carrying particles circulate; they are markers, not outcomes.

3

Absorbed tocopherols and catechins

After pecan test meals, plasma gamma-tocopherol doubled at 8 hours, epigallocatechin-3-gallate rose at 1 to 2 hours and oxidized LDL fell for up to 8 hours after whole pecans. Over 4 weeks of pecan feeding, antioxidant, oxidative stress and inflammation markers did not differ from a matched control diet.

Clinical trials

1
57 g of Pecans a Day in Place of Usual Snacks for 12 Weeks: Vessel Function (null primary)
PubMed

Single-blinded randomized parallel trial; 57 g a day of pecans in place of usual snacks versus continuing the usual diet (not calorie-matched) for 12 weeks; flow-mediated dilation was the primary outcome; registered NCT05071807; funded by a grant from the American Pecan Council (Hart et al. 2025, Am J Clin Nutr)

138 adults (mean age 46, mean BMI 29.8) with at least one metabolic syndrome criterion and no cardiovascular disease or type 2 diabetes; 69 per group.

Flow-mediated dilation, pulse wave velocity and blood pressure did not differ between groups. Compared with usual diet, pecans lowered total cholesterol by 8.1 mg/dL, LDL by 7.2 mg/dL, non-HDL cholesterol by 9.5 mg/dL and triglycerides by 16.4 mg/dL, and raised the Healthy Eating Index by 9.4 points. Weight tended to rise 0.7 kg (95% CI -0.1 to 1.4).

2
Pecans at 6%, 13% or 20% of Daily Energy for 4 Weeks: Blood Lipids
PubMed

Single-blind randomized parallel superiority trial; raw pecans at 6%, 13% or 20% of estimated energy needs, swapped for foods of equal calories, versus a habitual nut-free diet for 4 weeks; fasting and after-meal lipids were among 15 registered primary outcomes that also included glucose, insulin, appetite, oxidative stress and inflammation measures; registered NCT05949879; funded by the American Pecan Promotion Board and the University of Georgia Obesity Research Initiative (Guadagni et al. 2026, J Nutr)

102 adults with BMI of 28 or more or dyslipidemia (26, 26 and 25 in the pecan groups, 25 controls).

Total cholesterol, LDL, apoB and non-HDL cholesterol fell in the 13% group (LDL -12.7 mg/dL) and the 20% group (LDL -11.9 mg/dL) compared with no change at 6% or in controls. Fasting and after-meal triglycerides did not differ between groups; after-meal free fatty acids fell only at 13%. These are blood markers.

3
Pecan-Rich vs Calorie-Matched Nut-Free Diet for 4 Weeks: Insulin Resistance Markers
PubMed

Randomized, blinded, controlled crossover feeding trial with all meals provided; whole pecans at 15% of energy (about 42.5 g per 2000 kcal) versus a nut-free control diet matched for calories, total fat and fiber, 4 weeks each with a 2-week washout; registered NCT01950806 with oxidative stress, inflammation, endothelial, antioxidant and insulin resistance markers as primary outcomes; supported by USDA ARS and the National Pecan Shellers Association, which supplied the pecans (McKay et al. 2018, Nutrients)

26 men and postmenopausal women aged 45 or older with overweight or obesity and central adiposity.

Changes in fasting insulin (P = 0.024), HOMA-IR (P = 0.037) and HOMA-beta (P = 0.021) favored the pecan diet. Total and LDL cholesterol differences were borderline (P = 0.056 and 0.067). Glucose, blood pressure, body weight and the oxidative stress, inflammation, endothelial and antioxidant markers did not differ. A composite risk score favored pecans (P = 0.009).

4
68 g of Pecans a Day, Added or Swapped, for 8 Weeks: Blood Lipids
PubMed

Randomized controlled parallel trial with two pecan groups, one adding 68 g a day to the free-living diet and one swapping it for foods of equal calories, versus a nut-free control for 8 weeks; fasting lipids were registered primary outcomes; registered NCT04376632, which lists the Georgia Pecan Commission as collaborator (Guarneiri et al. 2021, J Nutr)

56 adults with BMI of 28 or more or high cholesterol (reported groups: 18 control, 16 added, 18 swapped).

From baseline to 8 weeks, total cholesterol, LDL (143 to 129 mg/dL added; 144 to 135 mg/dL swapped), triglycerides, non-HDL cholesterol and apoB fell in both pecan groups, with no changes in controls. After-meal triglycerides fell in the added group and after-meal glucose in the swapped group. The abstract reports these as within-group changes.

5
68 g of Pecans a Day With or Without Swap Instructions: Body Weight Over 8 Weeks
PubMed

Randomized controlled parallel trial (registered NCT04376632, body weight a registered primary outcome); 68 g a day of pecans (about 470 kcal) added to the free-living diet or swapped for foods of equal calories, versus a nut-free control for 8 weeks; supported by the Georgia Pecan Commission (Guarneiri et al. 2022, J Nutr Sci)

106 adults randomized and 93 completed (30 added, 31 swapped, 32 control); mean age 44 to 47.

Weight rose 1.1 kg (added) and 0.9 kg (swapped) versus 0.3 kg in controls, a trend (P = 0.09), well below the 3.3 and 3.2 kg predicted from the extra calories. Body fat rose 1.0% in the swapped group only (P = 0.005). The authors concluded that 8 weeks of pecans did not cause significant weight gain.

6
30 g of Pecans a Day Added to a Healthy Diet for 12 Weeks: LDL in Adults With Stable Coronary Artery Disease (null primary)
PubMed

Randomized parallel trial; healthy diet plus 30 g a day of pecans, healthy diet plus 30 mL a day of extra-virgin olive oil, or healthy diet alone for 12 weeks; LDL cholesterol was the primary outcome; registered NCT02202265 (per a companion report), sponsored by Instituto de Cardiologia do Rio Grande do Sul with Brazilian public research funders (Campos et al. 2020, J Hum Nutr Diet)

204 adults aged 40 to 80 with stable coronary artery disease in Brazil (68 pecan, 69 olive oil, 67 control), intention-to-treat analysis.

After adjustment for baseline values and statin type, LDL cholesterol, the primary outcome, and HDL cholesterol did not differ between groups. Non-HDL cholesterol (114.9 versus 127 mg/dL in controls) and the total to HDL cholesterol ratio were lower with pecans. A companion report found no differences in glucose markers or body shape indexes, while diet quality scores were higher with pecans.

7
68 g of Pecans a Day vs Nut Avoidance for 4 Weeks: Vessel Function and Lipids in Older Adults
PubMed

Randomized controlled parallel trial; 68 g a day of pecans versus avoiding all nuts (not calorie-matched) for 4 weeks; registered NCT04385537 with flow-mediated dilation and other vascular measures as primary outcomes; the registry lists the American Pecan Council as collaborator (Cogan et al. 2023, Nutr Res)

44 older adults (mean age 59); 21 pecan and 23 control.

Fasting large-artery and small-vessel function did not change. After a meal, two small-vessel reactive hyperemia measures differed by group in favor of pecans (P = 0.04 and 0.004). Total cholesterol (-14 versus -0.2 mg/dL), LDL (-15 versus +1.9 mg/dL), non-HDL cholesterol and LDL particle number fell more with pecans, and after-meal triglycerides were suppressed in the pecan group only.

8
Pecans Replacing a Fifth of a Step I Diet: 4-Week Crossover on Blood Lipids
PubMed

Single-blind randomized controlled crossover feeding study; a Step I diet versus the same diet with every food cut by one fifth and replaced by pecans of equal calories (fat 39.6% versus 28.3% of energy), 4 weeks each; funding not stated in the abstract (Rajaram et al. 2001, J Nutr)

23 healthy adults (mean age 38; 14 men, 9 women) with normal to moderately high cholesterol.

Beyond the Step I diet, the pecan diet lowered total cholesterol by 6.7%, LDL by 10.4% and triglycerides by 11.1%, raised HDL by 2.5 mg/dL, and lowered apoB by 11.6% and lipoprotein(a) by 11.1% (all P < 0.05), without raising body weight. These are blood markers in a small, short study.

Side effects and drug interactions

Common Potential side effects

Tree nut allergy: FDA lists tree nuts among the nine major food allergens, and labels must name the type of tree nut (for example, pecans). Reactions range from hives and lip swelling to life-threatening anaphylaxis. Walnut and pecan are highly cross-reactive, so people with a walnut or other tree nut allergy should avoid pecans unless an allergist advises otherwise.
Calories: USDA lists 691 kcal per 100 g (about 194 kcal per 28 g), and the 68 g a day used in several trials supplies about 470 kcal. Weight tended to rise about 1 kg over 8 weeks in one trial, so eat pecans in place of other foods rather than on top of them.
Pecan oil, pecan flour and extracts: the trials cited here used whole pecan kernels, so their results may not carry over to other pecan products.

Important Drug interactions

Cholesterol-lowering medicines: pecans lowered LDL slightly in short trials, and in a 12-week trial in coronary patients the analysis was adjusted for statin type. Do not change a prescription on your own.
No formal drug interaction studies of pecans were found among the sources reviewed for this page; ask your pharmacist about concentrated pecan extracts, which these trials did not test.

Frequently asked questions about Pecan (Carya illinoinensis)

What has FDA said about health claims on pecan labels?

In 2003 FDA said it would consider enforcement discretion, rather than authorize a health claim, for this qualified claim on whole or chopped pecans and most other nuts: "Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts [, such as name of specific nut,] as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease. [See nutrition information for fat content.]" Naming the specific nut is optional, and the fat disclosure applies to whole or chopped nuts. Pecans were named in the petition and are not among the nuts FDA left out for saturated fat (Brazil nuts, macadamia nuts, cashews and some pine nuts). Nut-containing products need at least 11 g of qualifying nuts per reference amount and must be low in saturated fat and cholesterol.

How many pecans were used in the studies?

Most trials gave 57 to 68 g a day (about 2 to 2.4 ounces) for 4 to 12 weeks; a Brazilian trial used 30 g a day, and feeding trials set pecans at 13 to 20% of daily energy. In a dose trial, 6% of energy did not change blood lipids while 13% and 20% did. FDA's qualified claim names 1.5 ounces (about 42 g) a day. A 28 g handful supplies about 194 kcal.

Do pecans cause weight gain?

Not significantly in the trials cited here, though they are calorie dense. In an 8-week trial, 68 g a day raised weight about 1 kg against 0.3 kg in controls, a trend that did not reach significance and was far less than the extra calories predicted, and a 12-week trial found a similar trend of 0.7 kg. Pooled trials found no change in weight, BMI or waist. Eating pecans in place of other foods keeps calories in check.

Who paid for the pecan studies?

Most US trials cited here had pecan industry support: the American Pecan Council (12-week snack trial and a 4-week vessel trial, per its registry entry), the American Pecan Promotion Board (dose trial), the Georgia Pecan Commission (8-week trials) and the National Pecan Shellers Association with USDA (4-week feeding trial). A Brazilian trial in coronary patients was publicly funded and found no LDL change, its primary outcome.

Who should avoid pecans?

Anyone with a pecan, walnut or other tree nut allergy. FDA lists tree nuts among the nine major food allergens and requires labels to name pecans when present, and walnut and pecan are highly cross-reactive. People watching calories should eat pecans in place of other foods rather than in addition to them.

What is Pecan?

Pecans are the nuts of the pecan hickory tree (Carya illinoinensis), eaten raw, roasted, chopped or ground. Per 100 g, USDA lists 691 kcal, 72 g of fat (40.8 g monounsaturated), 9.2 g of protein, 9.6 g of fiber and 24.4 mg of gamma-tocopherol, so a 28 g handful supplies about 194 kcal.

What is Pecan used for?

NutraSmarts does not list Pecan under a health category. What the research covers: A pooled analysis of 10 trial reports found pecans lowered total cholesterol by 8.5 mg/dL, LDL by 7.4 mg/dL and triglycerides by 14.1 mg/dL more than control diets, rating certainty as low.

What is the recommended dosage of Pecan?

The clinically studied dose is Whole pecans: 57 to 68 g a day (about 2 to 2.4 oz) for 4 to 12 weeks in most trials; 30 g a day in a 12-week trial; 13% or 20% of daily energy in other trials, with no lipid change at 6%. FDA's qualified nut claim names 1.5 ounces (about 42 g) a day. Always follow the product label and check with a healthcare provider for personal advice.

Is Pecan safe, and does it have side effects?

Side effects and cautions reported for Pecan include: Tree nut allergy: FDA lists tree nuts among the nine major food allergens, and labels must name the type of tree nut (for example, pecans). Reactions range from hives and lip swelling to life-threatening anaphylaxis. It may also interact with some medications. Pecan is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Pecan interact with any medications?

Possible interactions include: Cholesterol-lowering medicines: pecans lowered LDL slightly in short trials, and in a 12-week trial in coronary patients the analysis was adjusted for statin type. Do not change a prescription on your own. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Pecan?

NutraSmarts rates the evidence for Pecan as Limited (2 out of 5). It is backed by 8 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(16 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Zhang Z, Sohouli MH. The effect of pecan consumption on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2026;18(1):180. doi: 10.1186/s13098-026-02212-1.PubMedUsed to support: Random-effects meta-analysis of randomized trials searched to November 2025 (10 trial reports, 4 to 12 weeks, 30 to 68 g a day; controls were usual or nut-free diets in most, isocaloric control diets in some). Pecans lowered total cholesterol by 8.49 mg/dL, LDL by 7.42 mg/dL and triglycerides by 14.06 mg/dL (7 studies each, I2 = 0%), with little evidence of an effect on HDL, fasting glucose (I2 = 71.2%), insulin, HOMA-IR, body weight, BMI, waist, or systolic and diastolic blood pressure (I2 = 88.8% and 89.6%). GRADE certainty for lipid outcomes was low. The included-study table lists two reports of the same Brazilian 12-week trial and two reports of the same Georgia 4-week trial, so about 8 independent trials were pooled. The authors reported no funding and no competing interests.
  2. Hart TL, Kris-Etherton PM, Petersen KS. Consuming pecans as a snack improves lipids/lipoproteins and diet quality compared with usual diet in adults at increased risk of cardiometabolic diseases: a randomized controlled trial. Am J Clin Nutr. 2025;121(4):769-778. doi: 10.1016/j.ajcnut.2025.01.024.PubMedUsed to support: 12-week single-blinded parallel trial in 138 adults with at least one metabolic syndrome criterion: 57 g a day of pecans replacing usual snacks versus continuing the usual diet. Flow-mediated dilation (primary outcome), pulse wave velocity and blood pressure did not differ. Pecans lowered total cholesterol by 8.1 mg/dL, LDL by 7.2 mg/dL, non-HDL by 9.5 mg/dL and triglycerides by 16.4 mg/dL, raised the Healthy Eating Index by 9.4 points, and weight tended to rise 0.7 kg. Registered NCT05071807; two authors received a grant from the American Pecan Council.
  3. Guadagni AJ, Paton CM, Cooper JA. Dose-Response Effects of Pecan Consumption on Blood Lipid Profiles in Adults with Excess Body Weight and/or Dyslipidemia: a Randomized Controlled Trial. J Nutr. 2026;156(4):101396. doi: 10.1016/j.tjnut.2026.101396.PubMedUsed to support: Single-blind randomized trial in 102 adults with excess body weight or dyslipidemia: pecans at 6%, 13% or 20% of energy needs, substituted for foods of equal calories, or a habitual nut-free diet for 4 weeks. Total, LDL and non-HDL cholesterol and apoB fell at 13% and 20% but not at 6% or in controls; fasting and after-meal triglycerides did not differ, and after-meal free fatty acids fell only at 13%. Registered NCT05949879; funded by the American Pecan Promotion Board and the University of Georgia Obesity Research Initiative (PMC full text).
  4. McKay DL, Eliasziw M, Chen CYO, Blumberg JB. A Pecan-Rich Diet Improves Cardiometabolic Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. Nutrients. 2018;10(3):339. doi: 10.3390/nu10030339.PubMedUsed to support: Randomized controlled crossover feeding trial in 26 adults aged 45 or older with overweight or obesity: a diet with pecans at 15% of energy versus a nut-free diet matched for calories, fat and fiber, 4 weeks each. Changes in fasting insulin, HOMA-IR and HOMA-beta favored pecans; total and LDL cholesterol differences were borderline; glucose, blood pressure, body weight and oxidative stress, inflammation and endothelial markers did not differ; red blood cell oleic acid rose. Registered NCT01950806; supported by USDA ARS and the National Pecan Shellers Association, which supplied the pecans (PMC full text).
  5. Guarneiri LL, Paton CM, Cooper JA. Pecan-Enriched Diets Alter Cholesterol Profiles and Triglycerides in Adults at Risk for Cardiovascular Disease in a Randomized, Controlled Trial. J Nutr. 2021;151(10):3091-3101. doi: 10.1093/jn/nxab248.PubMedUsed to support: 8-week randomized trial in 56 adults with BMI of 28 or more or high cholesterol: 68 g a day of pecans added to the diet, 68 g swapped for foods of equal calories, or a nut-free control. Fasting total cholesterol, LDL, triglycerides, non-HDL cholesterol and apoB fell within both pecan groups with no changes in controls; after-meal triglycerides fell in the added group and after-meal glucose in the swapped group. Registered NCT04376632, whose registry entry lists the Georgia Pecan Commission as collaborator.
  6. Guarneiri LL, Paton CM, Cooper JA. Changes in body weight in response to pecan-enriched diets with and without substitution instructions: a randomised, controlled trial. J Nutr Sci. 2022;11:e16. doi: 10.1017/jns.2022.14.PubMedUsed to support: 8-week randomized trial (93 completers): 68 g a day of pecans added or swapped for foods of equal calories versus a nut-free control. Weight rose 1.1 and 0.9 kg versus 0.3 kg in controls (trend, P = 0.09), less than the 3.3 and 3.2 kg predicted; body fat rose only in the swapped group. Registered NCT04376632; supported by the Georgia Pecan Commission (PMC full text).
  7. Campos VP, Portal VL, Markoski MM, Quadros AS, Bersch-Ferreira ÂC, Garavaglia J, Marcadenti A. Effects of a healthy diet enriched or not with pecan nuts or extra-virgin olive oil on the lipid profile of patients with stable coronary artery disease: a randomised clinical trial. J Hum Nutr Diet. 2020;33(3):439-450. doi: 10.1111/jhn.12727.PubMedUsed to support: 12-week randomized trial in 204 adults with stable coronary artery disease in Brazil: healthy diet alone, plus 30 g a day of pecans, or plus 30 mL a day of extra-virgin olive oil. LDL cholesterol, the primary outcome, did not differ between groups after adjustment for baseline values and statin type; non-HDL cholesterol and the total to HDL cholesterol ratio were lower with pecans. The registry entry for this trial (NCT02202265) lists Instituto de Cardiologia do Rio Grande do Sul as sponsor with Brazilian public research funders.
  8. Dos Santos JL, Portal VL, Markoski MM, de Quadros AS, Bersch-Ferreira Â, Marcadenti A. Effect of pecan nuts and extra-virgin olive oil on glycemic profile and nontraditional anthropometric indexes in patients with coronary artery disease: a randomized clinical trial. Eur J Clin Nutr. 2022;76(6):827-834. doi: 10.1038/s41430-021-01045-7.PubMedUsed to support: Report from the same 12-week Brazilian trial of 204 adults with stable coronary artery disease (healthy diet alone, plus 30 g a day of pecans, or plus 30 mL a day of extra-virgin olive oil): the triglyceride-glucose index, the primary outcome of this report, other glucose markers and body shape indexes did not differ between groups after adjustment. Diet quality scores (mAHEI) were higher with pecans (26 versus 19 in controls). Registered NCT02202265.
  9. Cogan B, Pearson RC, Paton CM, Jenkins NT, Cooper JA. Pecan-enriched diet improves cholesterol profiles and enhances postprandial microvascular reactivity in older adults. Nutr Res. 2023;111:44-58. doi: 10.1016/j.nutres.2023.01.001.PubMedUsed to support: 4-week randomized trial in 44 older adults: 68 g a day of pecans versus avoiding all nuts. Total cholesterol, LDL, non-HDL cholesterol, LDL particle number and medium LDL fell more with pecans; after-meal triglycerides were suppressed in the pecan group; two after-meal reactive hyperemia measures differed by group, while fasting large-artery and small-vessel function did not change. Registered NCT04385537, whose registry entry lists vascular measures as primary outcomes and the American Pecan Council as collaborator.
  10. Rajaram S, Burke K, Connell B, Myint T, Sabaté J. A monounsaturated fatty acid-rich pecan-enriched diet favorably alters the serum lipid profile of healthy men and women. J Nutr. 2001;131(9):2275-9. doi: 10.1093/jn/131.9.2275.PubMedUsed to support: Single-blind randomized crossover feeding study in 23 adults with normal to moderately high cholesterol: a Step I diet versus a diet in which pecans replaced one fifth of the Step I foods at equal calories, 4 weeks each. The pecan diet lowered total cholesterol 6.7%, LDL 10.4%, triglycerides 11.1%, apoB 11.6% and lipoprotein(a) 11.1% and raised HDL by 2.5 mg/dL beyond the Step I diet, without raising body weight. Funding is not stated in the abstract.
  11. Hudthagosol C, Haddad EH, McCarthy K, Wang P, Oda K, Sabaté J. Pecans acutely increase plasma postprandial antioxidant capacity and catechins and decrease LDL oxidation in humans. J Nutr. 2011;141(1):56-62. doi: 10.3945/jn.110.121269.PubMedUsed to support: Randomized crossover test-meal study in 16 healthy adults aged 23 to 44: whole pecans, blended pecans or an isocaloric meal of refined ingredients with matching macronutrients. After pecan meals, plasma gamma-tocopherol doubled at 8 hours and hydrophilic and lipophilic ORAC rose 12 and 10% at 2 hours; after whole pecans, oxidized LDL fell 26 to 33% at 2 to 8 hours and epigallocatechin-3-gallate was higher at 1 hour than after the control meal. A single-meal marker study; funding is not stated in the abstract.
  12. Peters JC, Breen JA, Pan Z, Nicklas J, Cornier MA. A Randomized, Crossover Trial Assessing Appetite, Energy Metabolism, Blood Biomarkers, and Ad Libitum Food Intake Responses to a Mid-Morning Pecan Snack vs. an Equicaloric High-Carbohydrate Snack in Healthy Volunteers with Overweight/Obesity. Nutrients. 2024;16(13):2084. doi: 10.3390/nu16132084.PubMedUsed to support: Randomized crossover trial in 20 adults with overweight or obesity: a single 250 kcal mid-morning snack of pecans or tortilla chips. Appetite ratings, lunch energy intake and energy expenditure did not differ; glucose and insulin rose less after pecans, while free fatty acids, triglycerides, PYY and GLP-1 were higher. A single-snack marker study. The registry entry (NCT04484974) labels the comparator arm tortilla chips but describes it as pretzels, and the paper reports tortilla chips. Two authors received funding from the American Pecan Council, and NIH/NCATS also supported the work (PMC full text).
  13. Smeekens JM, Bagley K, Kulis M. Tree nut allergies: Allergen homology, cross-reactivity, and implications for therapy. Clin Exp Allergy. 2018;48(7):762-772. doi: 10.1111/cea.13163.PubMedUsed to support: Review: tree nut allergy affects about 1% of the US population and is outgrown in fewer than 10% of cases; walnut and pecan are highly cross-reactive, as are cashew and pistachio, and the current guideline is strict avoidance of all nuts once one tree nut allergy is diagnosed.
  14. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition (Taylor CL). Qualified Health Claims: Letter of Enforcement Discretion - Nuts and Coronary Heart Disease (Docket No 02P-0505). U.S. Food and Drug Administration. 2003;Letter dated July 14, 2003, to the International Tree Nut Council Nutrition Research and Education Foundation; archived FDA.gov page captured November 14, 2017; accessed 2026..SourceUsed to support: Not PubMed-indexed; archived FDA letter read. The petition named peanuts and nine tree nuts, including pecans. FDA did not authorize a health claim but will consider enforcement discretion for the qualified claim "Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts [, such as name of specific nut,] as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease. [See nutrition information for fat content.]" The fat disclosure applies to whole or chopped nuts. FDA excluded nuts above the saturated fat disqualifying levels (Brazil nuts, macadamia nuts, cashew nuts and some varieties of pine nuts); nut-containing products need at least 11 g of qualifying nuts per reference amount customarily consumed (RACC) and must meet the low saturated fat and low cholesterol definitions.
  15. U.S. Department of Agriculture, Agricultural Research Service. Nuts, pecans (SR Legacy, FDC ID 170182). FoodData Central. USDA FoodData Central. 2019;SR Legacy, NDB number 12142; record last updated April 1, 2019. Accessed 2026..SourceUsed to support: Not PubMed-indexed; USDA food composition entry for Carya illinoinensis. Per 100 g of pecans: 691 kcal, 9.17 g protein, 72.0 g fat (40.8 g monounsaturated, 21.6 g polyunsaturated including 20.6 g linoleic acid and 0.986 g ALA, 6.18 g saturated), 13.9 g carbohydrate, 9.6 g dietary fiber, 1.4 mg alpha-tocopherol, 24.4 mg gamma-tocopherol, 117 mg beta-sitosterol, 121 mg magnesium and 4.5 mg manganese. No polyphenol values are listed.
  16. U.S. Food and Drug Administration. Food Allergies. U.S. Food and Drug Administration. 2026;Web page, content current as of 03/11/2026. Accessed 2026..SourceUsed to support: Not PubMed-indexed; FDA consumer page read in 2026. Lists the nine major food allergens (milk, eggs, fish, Crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame), states that labels must name the type of tree nut (for example, almonds, pecans, walnuts), and notes that reactions range from hives and lip swelling to life-threatening anaphylaxis.